ABOUT THE SPEAKERS

Jeffrey J. Auletta, MD
Chief Scientific Officer
Center for International Blood and Marrow Transplant Research (CIBMTR)
SVP CIBMTR & Clinical Services NMDP

At NMDP, I provide team leadership and strategic oversight for the organization's research programs and health equity efforts, including the ASTCT NMDP ACCESS Initiative. The ACCESS Initiative is a collaborative effort to address and reduce access barriers and outcome disparities for all patients in need of cell therapy involving stakeholders across the ecosystem.

Along with the Chief Scientific Director, Center for International Blood & Marrow Transplant Research (CIBMTR) at the Medical College of Wisconsin, I co-lead the CIBMTR in advancing the successful application of hematopoietic cell transplant (HCT) and cell therapy through observational and prospective research, most notably the NMDP-sponsored, CIBMTR-led mismatched unrelated donor (MMUD) HCT clinical trial portfolio. 

Both my NMDP and CIBMTR roles involve collaborating with academic centers and industry partners in advancing the field of cell therapy, ensuring equal access to these therapies, and striving to transform the post-transplant outcome landscape by improving patient survival and quality of life.

Kirby Eng
Chief Clinical Officer
OutcomeRx

Kirby brings extensive experience across a broad spectrum of senior and executive leadership roles within the healthcare industry. His background spans managed care, specialty pharmacy, oncology utilization management strategies, business development, healthcare consulting, healthcare technology, provider network development, group purchasing, specialty distribution, and pharmaceutical manufacturing.

As Chief Clinical Officer at OutcomeRx, Kirby leads the development and implementation of patient-centered clinical solutions for cell and gene therapies. His work focuses on aligning stakeholders with cost-effective approaches that complement OutcomeRx’s insurance solutions. He also oversees the implementation of personalized patient support services that address both the clinical and financial complexities associated with advanced therapies, while also considering the needs of caregivers.

Tom Sondergeld
Sr. Director, Analytics, Research & Solutions Employer
Merative

With over 30 years of experience in health benefits consulting, I specialize in data analysis, customer success, and business growth strategies. As Senior Director of Analytics, Research & Solutions at Merative, I lead the development and implementation of analytics strategies, collaborate with cross-functional teams to enhance decision-making, and mentor a team of analysts to foster innovation and growth. 

My career has focused on advancing health-related point solutions and partnering with employers to optimize benefits strategies. I am dedicated to leveraging data-driven insights to support organizations in achieving operational efficiencies while delivering impactful and tailored solutions to meet client needs.

Drew Wilkins
Managing Director
Deloitte Consulting

Nearly 20 years of consulting experience focusing on life sciences and healthcare corporate strategy and innovation. My recent work focuses on helping clients solve the strategic challenges associated with major transformations and business model innovation. Much of this work also focuses on the future of healthcare, disruptive business model and innovations in market access. I am passionate about helping patients get the health care they need and deserve. I lead Deloitte's innovative financing practice for commercial life sciences.